Kolexia
Macintyre Elizabeth Hématologie
Macintyre Elizabeth
Hématologie
Hôpital Necker Enfants Malades
Paris, France
236 Activités
275 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Leucémie-lymphome lymphoblastique à précurseurs T Leucémie-lymphome lymphoblastique à précurseurs B et T Lymphome à cellules du manteau Maladie résiduelle Lymphome T Prédisposition génétique à une maladie Leucémie aigüe myéloïde

Collaborateurs

Voir plus
Asnafi Vahid
Asnafi Vahid
Hôpital Necker Enfants Malades, Paris, France
Hermine Olivier
Hermine Olivier
Hôpital Necker Enfants Malades, Paris, France
Dombret Herve
Dombret Herve
Hôpital Saint-Louis, Paris, France
Lhermitte Ludovic
Lhermitte Ludovic
Hôpital Necker Enfants Malades, Paris, France

Industries

Voir plus
Servier
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
Waiting in Pain II: An updated analysis of the multidisciplinary staffing levels and clinical activity in Australian specialist persistent pain services.
The journal of pain   13 décembre 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   22 novembre 2023
Obinutuzumab Versus Rituximab in Transplant Eligible Untreated MCL Patients, a Matching Comparison between the Lyma and Lyma-101 Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optical Genome Mapping Provides New Molecular Insights in High-Risk Mantle Cell Lymphoma: A Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
The oncogenetic landscape and clinical impact of alterations in adult and pediatric T-cell acute lymphoblastic leukemia.
Haematologica   01 novembre 2023
PHF6-altered T-ALL harbor epigenetic repressive switch at bivalent promoters and respond to 5-azacitidine and venetoclax.
Clinical cancer research : an official journal of the American Association for Cancer Research   27 octobre 2023
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Scientific reports   24 octobre 2023